| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.159 | 8.479 | 28.331 | 22.667 | 27.035 | 33.849 | 60.591 | 39.607 | 35.631 | 49.390 |
| Total Income - EUR | 11.159 | 8.479 | 28.331 | 22.667 | 27.035 | 50.388 | 60.591 | 39.607 | 35.631 | 49.390 |
| Total Expenses - EUR | 9.342 | 8.372 | 16.287 | 15.060 | 13.225 | 36.752 | 29.728 | 28.316 | 23.793 | 42.144 |
| Gross Profit/Loss - EUR | 1.817 | 107 | 12.044 | 7.607 | 13.810 | 13.635 | 30.863 | 11.291 | 11.837 | 7.246 |
| Net Profit/Loss - EUR | 1.483 | -63 | 11.137 | 7.380 | 13.540 | 13.153 | 30.257 | 10.688 | 10.098 | 6.093 |
| Employees | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Angyss Intermed Imob Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 20.423 | 30.030 | 26.792 | 23.620 | 26.150 | 28.968 | 94.416 | 107.833 | 104.699 | 150.145 |
| Current Assets | 1.453 | 1.381 | 4.863 | 11.766 | 12.042 | 21.670 | 52.159 | 24.876 | 6.400 | 24.730 |
| Inventories | 786 | 299 | 294 | 289 | 263 | 258 | 0 | 0 | 0 | 0 |
| Receivables | 606 | 1.077 | 3.147 | 1.884 | 3.856 | 11.223 | 12.602 | 23.022 | 6.142 | 23.211 |
| Cash | 61 | 5 | 1.422 | 9.593 | 7.922 | 10.189 | 39.556 | 1.854 | 258 | 1.520 |
| Shareholders Funds | -3.599 | -3.625 | 7.573 | 7.432 | 15.770 | 23.662 | 53.395 | 64.249 | 74.151 | 79.830 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 25.475 | 35.036 | 24.082 | 27.954 | 22.422 | 26.976 | 93.180 | 68.461 | 36.960 | 95.057 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Angyss Intermed Imob Srl